David Lawrence
2013
In 2013, David Lawrence earned a total compensation of $1.2M as Chief of Business Operations and Former Chief Financial Officer at Acorda Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $127,073 |
|---|---|
| Option Awards | $535,206 |
| Salary | $312,689 |
| Stock Awards | $221,503 |
| Other | $7,650 |
| Total | $1,204,121 |
Lawrence received $535.2K in option awards, accounting for 44% of the total pay in 2013.
Lawrence also received $127.1K in non-equity incentive plan, $312.7K in salary, $221.5K in stock awards and $7.7K in other compensation.
Rankings
In 2013, David Lawrence's compensation ranked 5,832nd out of 12,286 executives tracked by ExecPay. In other words, Lawrence earned more than 52.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,832 out of 12,286 | 53rd |
Division Manufacturing | 2,024 out of 4,612 | 56th |
Major group Chemicals And Allied Products | 592 out of 1,462 | 60th |
Industry group Drugs | 425 out of 1,156 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 64 out of 196 | 67th |
Source: SEC filing on April 25, 2014.
Lawrence's colleagues
We found six more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2013.
2013
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2013
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2013
Jane Wasman
Acorda Therapeutics
General Counsel
2013
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2013
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2013
Lauren Sabella
Acorda Therapeutics